<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=Generator content="Microsoft Word 15 (filtered)">
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin:0in;
	text-autospace:none;
	font-size:11.0pt;
	font-family:"Arial",sans-serif;}
h2
	{mso-style-link:"Heading 2 Char";
	margin-top:.25in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	page-break-after:avoid;
	text-autospace:none;
	font-size:11.0pt;
	font-family:"Arial",sans-serif;}
h3
	{mso-style-link:"Heading 3 Char";
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	page-break-after:avoid;
	text-autospace:none;
	font-size:11.0pt;
	font-family:"Arial",sans-serif;
	text-decoration:underline;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{mso-style-link:"Header Char";
	margin:0in;
	text-autospace:none;
	font-size:11.0pt;
	font-family:"Arial",sans-serif;}
a:link, span.MsoHyperlink
	{color:blue;
	text-decoration:underline;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	font-size:11.0pt;
	font-family:"Arial",sans-serif;
	border:none;}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParagraphCxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	font-size:11.0pt;
	font-family:"Arial",sans-serif;
	border:none;}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListParagraphCxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	font-size:11.0pt;
	font-family:"Arial",sans-serif;
	border:none;}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagraphCxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	font-size:11.0pt;
	font-family:"Arial",sans-serif;
	border:none;}
span.Heading2Char
	{mso-style-name:"Heading 2 Char";
	mso-style-link:"Heading 2";
	font-family:"Arial",sans-serif;
	font-weight:bold;}
span.Heading3Char
	{mso-style-name:"Heading 3 Char";
	mso-style-link:"Heading 3";
	font-family:"Arial",sans-serif;
	font-weight:bold;
	text-decoration:underline;}
span.HeaderChar
	{mso-style-name:"Header Char";
	mso-style-link:Header;
	font-family:"Arial",sans-serif;}
p.DataField11pt-Single, li.DataField11pt-Single, div.DataField11pt-Single
	{mso-style-name:"Data Field 11pt-Single";
	mso-style-link:"Data Field 11pt-Single Char";
	margin:0in;
	text-autospace:none;
	font-size:11.0pt;
	font-family:"Arial",sans-serif;}
span.DataField11pt-SingleChar
	{mso-style-name:"Data Field 11pt-Single Char";
	mso-style-link:"Data Field 11pt-Single";
	font-family:"Arial",sans-serif;}
p.h3underline, li.h3underline, div.h3underline
	{mso-style-name:h3_underline;
	margin-top:11.0pt;
	margin-right:0in;
	margin-bottom:1.5pt;
	margin-left:0in;
	page-break-after:avoid;
	font-size:14.0pt;
	font-family:"Times New Roman",serif;
	border:none;
	font-weight:bold;
	text-decoration:underline;}
.MsoChpDefault
	{font-family:"Calibri",sans-serif;}
.MsoPapDefault
	{margin-bottom:8.0pt;
	line-height:107%;}
@page WordSection1
	{size:8.5in 11.0in;
	margin:.5in .5in .5in .5in;}
div.WordSection1
	{page:WordSection1;}
 /* List Definitions */
 ol
	{margin-bottom:0in;}
ul
	{margin-bottom:0in;}
-->
</style>

</head>

<body lang=EN-US link=blue vlink="#954F72" style='word-wrap:break-word'>

<div class=WordSection1>

<p class=MsoNormal><span style='font-size:14.0pt'>A fundamental and unresolved
question in neuroscience is how the billions of interconnected neurons in the
brain coordinate their activity to support learning, memory, and decision
making. Neuromodulators such as dopamine and neural oscillatory activity play key
roles in organizing the activities of neurons and in supporting neuroplasticity.
Disrupted oscillatory activity during sleep and waking behavior and dopamine
release also contribute to disease states such as age-associated cognitive
decline, substance abuse, depression, and Parkinson’s disease (PD). My research
seeks to understand now neural oscillations, ensemble activity, and dopamine
release are coordinated during behavior and sleep to support learning and
memory. Towards this end, my laboratory measures single-unit and local-field
activity and dopamine release in behaving, sleeping, and anesthetized rats. Our
group has also developed novel instrumentation that allows, for the first time,
simultaneous measurement of the activities of large groups of neurons and fast,
“phasic” changes in dopamine release (Parent et al., 2017). We have also
recently integrated Neuropixels probes into our data-acquisition pipeline. </span></p>

<p class=MsoNormal style='line-height:50%'><span style='font-size:14.0pt;
line-height:50%'>&nbsp;</span></p>

<p class=MsoNormal><span style='font-size:14.0pt'>Through our investigations of
neural synchrony, sleep, and aging, we have found that normal aging is
associated with a significant decrease in the frequency of “ripple”
oscillations in the hippocampus during slow-wave sleep that are associated with
memory formation (Wiegand et al., 2016; Cowen et al., 2018). We have also performed
a detailed analysis of how the tuning of single-unit and local-field activity in
the hippocampus to locomotor information changes with age (Crown et al., 2022).
Our research surrounding Parkinson’s disease has also identified aberrant
patterns of sleep-spindle activity in a genetic form of Parkinson’s disease
(Crown et al., 2022) and how neural synchrony changes with the development of
levodopa-induced dyskinesia and low-dose ketamine administration (Ye et al.,
2021).</span></p>

<p class=MsoNormal style='line-height:50%'><span style='font-size:14.0pt;
line-height:50%'>&nbsp;</span></p>

<p class=MsoNormal><span style='font-size:14.0pt'>I am particularly excited
about my collaboration with Drs. Porreca and Navratilova to investigate how
opioids and pain impact sleep physiology. Drs. Porreca and Navratilova have
collaborated extensively, and we have co-authored two publications in the
journal Pain. To this project, I hope to bring nearly two decades of experience
in computational analysis of neural data, oscillatory activity during resting, sleeping,
and awake states, and statistics (I regularly teach a graduate-level statistics
classes in R) as well as decades of experience in electrophysiology. I have
also analyzed sleep/rest EEG in human and animal subjects.</span></p>

<p class=MsoNormal><span style='font-size:14.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span style='font-size:14.0pt'>Ongoing and recently
completed projects that I would like to highlight include:</span></p>

<p class=MsoNormal><span style='font-size:14.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span style='font-size:14.0pt'>R01 NIH BRAIN
(R01NS123424-01) </span></p>

<p class=MsoNormal><span style='font-size:14.0pt'>Cowen (PI) </span></p>

<p class=MsoNormal><i><span style='font-size:14.0pt'>8/1/21 - 7/31/26</span></i></p>

<p class=MsoNormal><span style='font-size:14.0pt'>Control of the time course of
dopamine release through optimized electrical brain stimulation                                                                                      </span></p>

<p class=MsoNormal><span style='font-size:14.0pt'>P30 NIH-NIDA (3042524)</span></p>

<p class=MsoNormal><span style='font-size:14.0pt'>Porreca (PI), Role: co-PI</span></p>

<p class=MsoNormal><span style='font-size:14.0pt'>07/01/21 - 06/31/26</span></p>

<p class=MsoNormal><span style='font-size:14.0pt'>Core Center of Excellence in
Addiction Studies </span></p>

<p class=MsoNormal><span style='font-size:14.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span style='font-size:14.0pt'>R01 NIH (NS122805-01) </span></p>

<p class=MsoNormal><span style='font-size:14.0pt'>Falk (PI), Role:
co-investigator</span></p>

<p class=MsoNormal><span style='font-size:14.0pt'>7/01/21 - 6/30/25</span></p>

<p class=MsoNormal><span style='font-size:14.0pt'>Mechanisms of low-dose
ketamine treatment for Parkinson's disease</span></p>

<p class=MsoNormal><span style='font-size:14.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span style='font-size:14.0pt'>R21 NIH (NS123512-01)</span></p>

<p class=MsoNormal><span style='font-size:14.0pt'>Miller (PI), role:
co-investigator</span></p>

<p class=MsoNormal><span style='font-size:14.0pt'>7/01/21 - 6/30/23</span></p>

<p class=MsoNormal><span style='font-size:14.0pt'>Alpha-synuclein driven
cellular changes and vocal dysfunction in Parkinson's Disease </span></p>

<p class=MsoNormal><span style='font-size:14.0pt'>&nbsp;</span></p>

<p class=MsoNormal><span style='font-size:14.0pt'>Citations:</span></p>

<p class=MsoListParagraphCxSpFirst style='text-indent:-.25in'><span
style='font-size:14.0pt;border:none'>1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><span style='font-size:14.0pt;border:none'><span
style='border:none'>Crown LM, Gray DT, Schimanski LA, Barnes CA, </span></span><b><span
style='font-size:14.0pt;border:none'><span style='border:none'>Cowen SL</span></span></b><span
style='font-size:14.0pt;border:none'><span style='border:none'> (2022) Aged
rats exhibit altered behavior-induced oscillatory activity, place cell firing
rates, and spa<span style='border:none'>tial information content in the CA1
region of the hippocampus. J Neurosci:<span style='border:none'> <span
style='border:none'>JN-RM-1855-21. <span style='border:none'>PMCID: PMC9172068<span
style='border:none'> </span></span></span></span></span></span></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-.25in'><span
style='font-size:14.0pt;border:none'>2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><span style='font-size:14.0pt;border:none'><span
style='border:none'>Ye T, Bartlett MJ, Sherman SJ, Falk T, </span></span><b><span
style='font-size:14.0pt;border:none'><span style='border:none'>Cowen SL</span></span></b><span
style='font-size:14.0pt;border:none'><span style='border:none'> (2021) Spectral
signatures of L-DOPA-induced dyskinesia depend on L-DOPA dose and are
suppressed by<span style='border:none'> ketamine. Experimental Neurology
340:113670. <span style='border:none'>PMCID: PMC9191762</span></span></span></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-.25in'><span
style='font-size:14.0pt;border:none'>3.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><span style='font-size:14.0pt;border:none'><span
style='border:none'>Crown, LM, Bartlett, MJ, Wiegand, JL, Eby, AJ, Monroe, EJ,
Gies, K., Wohlford, L, Fell, MJ, Falk, T, &amp; </span></span><b><span
style='font-size:14.0pt;border:none'><span style='border:none'>Cowen, SL</span></span></b><span
style='font-size:14.0pt;border:none'><span style='border:none'> (2020). Sleep
Spindles and Fragmented Sleep as Prodromal Markers in a Preclinic<span
style='border:none'>al Model of LRRK2-G2019S Parkinson’s Disease. Frontiers in
Neurology, 11, 324. PMID: 32477237, PMCID: PMC7232828. </span></span></span></p>

<p class=MsoListParagraphCxSpLast style='text-indent:-.25in'><span
style='font-size:14.0pt;border:none'>4.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><span style='font-size:14.0pt;border:none'><span
style='border:none'>Parent KL, Hill DF, Crown LM, Wiegand J-P, Gies KF, Miller
MA, Atcherley CW, Heien ML, </span></span><b><span style='font-size:14.0pt;
border:none'><span style='border:none'>Cowen SL</span></span></b><span
style='font-size:14.0pt;border:none'><span style='border:none'> (2017) Platform
to enable combined measuremen<span style='border:none'>t of dopamine and neural
activity. Anal Chem:acs.analchem.6b03642. PMCID: PMC6816331. </span></span></span></p>

<p class=DataField11pt-Single><strong><span style='font-size:14.0pt;font-family:
"Arial",sans-serif;color:#00B050'>&nbsp;</span></strong></p>

<p class=DataField11pt-Single style='margin-left:.25in;text-indent:-.25in'><strong><span
style='font-size:14.0pt;font-family:"Arial",sans-serif'>A.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></strong><strong><span
style='font-size:14.0pt;font-family:"Arial",sans-serif'>Positions, Scientific
Appointments, and Honors</span></strong></p>

<p class=DataField11pt-Single style='margin-left:.25in;line-height:50%'><strong><span
style='font-size:14.0pt;line-height:50%;font-family:"Arial",sans-serif'>&nbsp;</span></strong></p>

<p class=h3underline style='margin:0in'><span style='font-family:"Arial",sans-serif;
border:none;text-decoration:none'><span style='border:none'>Positions and <span
style='border:none'>Scientific Appointments</span></span></span></p>

<p class=MsoNormal style='margin-left:1.5in;text-indent:-1.5in'><span
style='font-size:14.0pt'>2019 - Present     Associate Professor     University
of Arizona, Tucson, AZ</span></p>

<p class=MsoNormal style='margin-left:1.5in;text-indent:-1.5in'><span
style='font-size:14.0pt'>                              Department of Psychology</span></p>

<p class=MsoNormal style='margin-left:1.5in;text-indent:-1.5in'><span
style='font-size:14.0pt'>                              Graduate
Interdisciplinary Program in Neuroscience</span></p>

<p class=MsoNormal style='margin-left:1.5in;text-indent:-1.5in'><span
style='font-size:14.0pt'>                              Graduate
Interdisciplinary Program in Cognitive Science</span></p>

<p class=MsoNormal style='margin-left:1.5in;text-indent:-1.5in'><span
style='font-size:14.0pt'>                              Graduate
Interdisciplinary Program in Physiological Sciences</span></p>

<p class=MsoNormal style='margin-left:1.5in;text-indent:-1.5in'><span
style='font-size:14.0pt'>                              Graduate
Interdisciplinary Program in Applied Biosciences</span></p>

<p class=MsoNormal><span style='font-size:14.0pt'>2018                     Invited
Member of Nu Rho Psi Neuroscience Honor Society </span></p>

<p class=MsoNormal style='margin-left:1.5in;text-indent:-1.5in'><span
style='font-size:14.0pt'>2012 - 2019         Assistant Professor University of
Arizona, Tucson, AZ</span></p>

<p class=MsoNormal style='margin-left:1.5in;text-indent:-1.5in'><span
style='font-size:14.0pt'>2010 - 2012         Associate Fellow, The
Neurosciences Institute, San Diego, CA</span></p>

<p class=MsoNormal style='margin-left:1.5in;text-indent:-1.5in'><span
style='font-size:14.0pt'>2008 - 2010         Research Fellow, The Neurosciences
Institute, San Diego, CA</span></p>

<p class=MsoNormal style='margin-left:1.5in;text-indent:-1.5in'><span
style='font-size:14.0pt'>2007 - 2008         Postdoctoral Fellow, The
Neurosciences Institute, San Diego, CA</span></p>

<p class=MsoNormal><span style='font-size:14.0pt'>1997 – Present     Member,
Society for Neuroscience</span></p>

<p class=MsoNormal style='margin-left:1.5in;text-indent:-1.5in'><span
style='font-size:14.0pt'>&nbsp;</span></p>

<p class=h3underline style='margin:0in'><span style='font-family:"Arial",sans-serif;
border:none;text-decoration:none'><span style='border:none'>Honors</span></span></p>

<p class=MsoNormal><span style='font-size:14.0pt'>1998 - 1999         Recipient
of a National Science Foundation training grant. </span></p>

<p class=MsoNormal style='margin-left:1.5in;text-indent:-1.5in'><span
style='font-size:14.0pt'>2010                     Awarded the Blasker-Rose-Miah
technology development grant from The San Diego Foundation.</span></p>

<p class=MsoNormal style='margin-left:1.5in;text-indent:-1.5in'><span
style='font-size:14.0pt'>&nbsp;</span></p>

<h2 style='margin:0in'><strong><span style='font-size:14.0pt;font-family:"Arial",sans-serif;
font-weight:normal'>C.      Contributions to Science</span></strong></h2>

<p class=MsoNormal><span style='font-size:14.0pt'>&nbsp;</span></p>

<h3 style='margin:0in;margin-bottom:.0001pt;text-indent:0in'><span
style='font-size:14.0pt;text-decoration:none'>1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><span style='font-size:14.0pt'>Aging and Parkinson’s disease are
associated with altered single-unit coordination and local-field activity during
sleep</span></h3>

<p class=MsoNormal style='margin-left:.5in'><span style='font-size:14.0pt'>The
hippocampus is critical for the formation of memories for episodes involving
places, events, and time. Episodic memory declines with age, suggesting that
age impacts neural processes involved in memory consolidation. Sharp-wave
ripples are high-frequency (~150 Hz) oscillations that occur primarily during
slow-wave NREM sleep and less frequently during waking immobility. Ripples are generated
in the hippocampus, and these oscillations are implicated in the stabilization
of long-term memories during sleep. Our analysis of ripples and of correlated
single-unit activity in rats during rest identified key age-associated changes
that correspond to memory impairment (Wiegand et al.). Specifically, aging was accompanied
by a decline in the ripple oscillation frequency, a reduced rate of ripple occurrence,
and reduced precision and reliability of neural activity during ripples.
Together, these changes may contribute to age-associated memory decline. Interestingly,
many of these changes were not found during active waking behavior (Cowen et
al. 2022). Furthermore, our examination of local-field activity during locomotor
behavior (Crown et al. 2022) revealed that behavior-associated oscillations in
the theta and gamma range was less tuned to sensorimotor input in aged animals,
suggesting that the aged brain is limited in its capacity to process rapidly
changing incoming information.  </span></p>

<p class=MsoNormal style='margin-left:.5in'><span style='font-size:14.0pt'>As
with hippocampal ripples, thalamocortical sleep spindles are also oscillatory
events that occur during NREM sleep and thought to be involved in the
consolidation of memory. Given evidence for the involvement of spindles in
motor memory, we explored whether features of spindles are altered in a genetic
form of Parkinson’s disease (Crown et al., 2020). While we found evidence for
sleep disruption in Parkinson’s disease, counter to our expectations, we
observed that spindle rate and spindle duration were increased in this genetic form
of the disease. </span></p>

<p class=MsoListParagraphCxSpFirst style='margin-left:1.0in;text-indent:-.25in'><span
style='font-size:14.0pt;border:none'>a.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><span style='font-size:14.0pt;border:none'><span
style='border:none'>Wiegand J-PL, Gray DT, Schimanski LA, Lipa P, Barnes CA, </span></span><b><span
style='font-size:14.0pt;border:none'><span style='border:none'>Cowen SL</span></span></b><span
style='font-size:14.0pt;border:none'><span style='border:none'> (2016) Age Is
Associated with Reduced Sharp-Wave Ripple Frequ<span style='border:none'>ency
and Altered Patterns of Neuronal Variability. J Neurosci 36:5650–5660.<span
style='border:none'> <span style='border:none'>PMCID: PMC5696526</span></span></span></span></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.0in;text-indent:-.25in'><span
style='font-size:14.0pt;border:none'>b.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><b><span style='font-size:14.0pt;border:none'><span
style='border:none'>Cowen SL</span></span></b><span style='font-size:14.0pt;
border:none'><span style='border:none'>, Gray DT, Wiegand J-PL, Schimanski LA,
Barnes CA. (2020). Age-associated changes in waking hippocampal sharp-wave
ripples. Hippocampus 30:28–38. <span style='border:none'>PMCID: <span
style='border:none'>PMC6322975</span></span></span></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.0in;text-indent:-.25in'><span
style='font-size:14.0pt;border:none'>c.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><span style='font-size:14.0pt;border:none'><span
style='border:none'>Crown, LM, Bartlett, MJ, Wiegand, JL, Eby, AJ, Monroe, EJ,
Gies, K., Wohlford, L, Fell, MJ, Falk, T, &amp; </span></span><b><span
style='font-size:14.0pt;border:none'><span style='border:none'>Cowen, SL</span></span></b><span
style='font-size:14.0pt;border:none'><span style='border:none'> (2020). Sleep
Spindles and Fragmented Sleep as Prodromal Markers in a Preclinical Model of
LRRK2-G2019S Parkinson’s Disease. Frontie<span style='border:none'>rs in
Neurology, 11, 324. PMCID: PMC7232828</span></span></span></p>

<p class=MsoListParagraphCxSpLast style='margin-left:1.0in;text-indent:-.25in'><span
style='font-size:14.0pt;border:none'>d.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><span style='font-size:14.0pt;border:none'><span
style='border:none'>Crown LM, Gray DT, Schimanski LA, Barnes CA, </span></span><b><span
style='font-size:14.0pt;border:none'><span style='border:none'>Cowen SL</span></span></b><span
style='font-size:14.0pt;border:none'><span style='border:none'> (2022) Aged
rats exhibit altered behavior-induced oscillatory activity, place cell firing
rates, and spatial information content in the CA1 region of the hipp<span
style='border:none'>ocampus. J <span style='border:none'>Neurosci: JN<span
style='border:none'>-RM-1855-21.  <span style='border:none'>PMCID: PMC9172068<br>
<br>
</span></span></span></span></span></span></p>

<h3 style='margin:0in;margin-bottom:.0001pt;text-indent:0in'><span
style='font-size:14.0pt;text-decoration:none'>2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><span style='font-size:14.0pt'>Ketamine induces brain-region
specific patterns of synchrony and desynchrony</span></h3>

<p class=MsoNormal style='margin-left:.5in'><span style='font-size:14.0pt'>In
the last decade, the potential therapeutic applications of ketamine have
expanded considerably. For example, hour to days-long exposure to
sub-anesthetic ketamine can provide weeks-long management of depression,
post-traumatic stress disorder (PTSD), chronic pain, and L-DOPA-induced
dyskinesias (LID). The neural mechanisms by which the therapeutic effects of
ketamine are achieved are unknown. Furthermore, little is known about how
ketamine alters neural coordination throughout the brain. Understanding the
impact of ketamine on neural coordination is important and neural plasticity
and communication between brain regions depends on the precise timing of action
potentials within and between brain structures. Consequently, we hypothesized
that hours-long exposure to ketamine entrains synchronized activity within
corticostriatal and hippocampal circuits. To investigate this question, we
measure oscillatory in the motor cortex, ventral striatum, dorsal striatum, and
hippocampus of behaving rats and found that ketamine induces unique patterns of
neural coordination in each brain region. Critically, we found that extended
exposure to ketamine hyper-synchronizes corticostriatal circuits at delta (~4
Hz), gamma (~50 Hz), and high-frequency (~140 Hz) bands while activity in the
hippocampus became desynchronized or “noisy”. These data suggest that ketamine
facilitates communication and plasticity in corticostriatal circuits and
disrupts these processes in the hippocampus. Indeed, desynchronous activity in
the hippocampus could reduce the strength of associative networks encoding
memories for negative events. Disrupting such networks could have positive
therapeutic effects in depression and PTSD. An important next step is to
determine if ketamine alters coordination in these brain regions though
single-unit ensemble recordings.</span></p>

<p class=MsoListParagraphCxSpFirst style='margin-left:1.0in;text-indent:-.25in'><span
style='font-size:14.0pt;border:none'>a.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><span style='font-size:14.0pt;border:none'><span
style='border:none'>Ye T, Bartlett MJ, Schmit MB, Sherman SJ, Falk T C, </span></span><b><span
style='font-size:14.0pt;border:none'><span style='border:none'>Cowen SL</span></span></b><span
style='font-size:14.0pt;border:none'><span style='border:none'> (20<span
style='border:none'>18) Ten-Hour Exposure to Low-Dose Ketamine Enhances
Corticostriatal Cross-Frequency Coupling and Hippocampal Broad-Band Gamma
Oscillations. Front. Neural Circuits 12, 61. <span style='border:none'>PMCID:
PMC6816331</span></span></span></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.0in;text-indent:-.25in'><span
style='font-size:14.0pt;border:none'>b.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><span style='font-size:14.0pt;border:none'><span
style='border:none'>Ye T, Bartlett MJ, Sherman SJ, Falk T, </span></span><b><span
style='font-size:14.0pt;border:none'><span style='border:none'>Cowen SL</span></span></b><span
style='font-size:14.0pt;border:none'><span style='border:none'> (2021) Spectral
sig<span style='border:none'>natures of L-DOPA-induced dyskinesia depend on
L-DOPA dose and are suppressed by ketamine. Experimental Neurology 340:113670. <span
style='border:none'>PMCID<span style='border:none'>:<span style='border:none'> <span
style='border:none'>PMC9191762<span style='border:none'>.</span></span></span></span></span></span></span></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.0in;text-indent:-.25in'><span
style='font-size:14.0pt;border:none'>c.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><span style='font-size:14.0pt;border:none'><span
style='border:none'>Bartlett MJ, Flores AJ, Ye T, Smidt SI, Dollish HK,
Stancati JA, Farrell DC, Parent KL, Doyle KP, Besselsen DG,<span
style='border:none'> Heien ML, </span></span></span><b><span style='font-size:
14.0pt;border:none'><span style='border:none'>Cowen SL</span></span></b><span
style='font-size:14.0pt;border:none'><span style='border:none'>, Steece-Collier
K, Sherman SJ, Falk T.<span style='border:none'> (2020)<span style='border:
none'> Preclinical evidence in support of repurposing sub-anesthetic ketamine
as a treatment for L-DOPA-induced dyskinesia. Experimental Neurology. Academic
Press Inc.; Nov 1;333.<span style='border:none'> PMCID: PMC7518549</span></span></span></span></span></p>

<p class=MsoListParagraphCxSpLast><span style='font-size:14.0pt;border:none'>&nbsp;</span></p>

<h3 style='margin:0in;margin-bottom:.0001pt;text-indent:0in'><span
style='font-size:14.0pt;text-decoration:none'>3.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><span style='font-size:14.0pt'>Anterior-cingulate neurons are
involved in post-decision action maintenance and value prediction.</span></h3>

<p class=MsoNormal style='margin-left:.5in'><span style='font-size:14.0pt'>The
anterior cingulate cortex, a subregion of the medial prefrontal cortex, plays a
critical role in the evaluation of the cost of physical effort. Evidence from
rodents and primates suggests that neurons in the anterior cingulate cortex
integrate information about expected effort to guide cost-benefit decision
making. To identify the physiological correlates of this evaluative process, I
used arrays of single-unit electrodes to record ensemble activity in the
anterior cingulate cortex as animals made effort- and reward-guided
evaluations. Unexpectedly, results indicated that neurons responding to the
anticipated effort responded at least 100 milliseconds<b> after</b> animals
made their decision, suggesting that these neurons do not contribute to
deliberation, but, instead, may be involved in sustaining goal-directed
behaviors after decisions are made. Our observations led me to the proposal
that the anterior cingulate cortex facilitates “perseverance” by regulating
glutamatergic and dopaminergic transmission in the motor cortex and dorsal
striatum. This proposal may have significant implications for the study of
chronic pain, a condition associated with reduced frontal function.
Consequently, my laboratory is now investigating the connection between chronic
pain and effort-guided decision making through our collaboration with Dr. Frank
Porreca.</span></p>

<p class=MsoListParagraph style='margin-left:1.0in;text-indent:-.25in'><span
style='font-size:14.0pt;border:none'>a.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><b><span style='font-size:14.0pt;border:none'><span
style='border:none'>Cowen SL</span></span></b><span style='font-size:14.0pt;
border:none'><span style='border:none'>, Davis GA., Nitz DA. (2012) Anterior
cingulate neurons in the rat map anticipated effort and reward to their
associated action sequ<span style='border:none'>ences. J <span
style='border:none'>Neurophysiology<span style='border:none'> 107:2393–2407.<span
style='border:none'> <br>
<span style='border:none'>Contribution: Experiment design and direction, data
analysis, wrote manuscript</span></span></span></span></span></span></span></p>

<p class=MsoListParagraph style='margin-left:1.0in;text-indent:-.25in'><span
style='font-size:14.0pt;border:none'>b.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><span style='font-size:14.0pt;border:none'><span
style='border:none'>Miller MA, Thomé A, </span></span><b><span
style='font-size:14.0pt;border:none'><span style='border:none'>Cowen SL</span></span></b><span
style='font-size:14.0pt;border:none'><span style='border:none'> (2013)
Intersection of effort and risk: ethological and neurobiological perspectives.
Front Neurosci 7:208.<span style='border:none'> PMCID: PMC3819579<br>
</span></span></span><b><span style='font-size:14.0pt;border:none'><span
style='border:none'>Cowen SL,</span></span></b><span style='font-size:14.0pt;
border:none'><span style='border:none'> Phelps CE, Navratilova, E, McKinzie DL,
Okun A, Husain O, Gleason SD, Witkin JM, Porreca, F., <span style='border:none'>(<span
style='border:none'>2018<span style='border:none'>)<span style='border:none'>.
Chronic pain impairs cognitive flexibility and engages novel learning
strategies in rats. Pain 1. <span style='border:none'>PMCID: PMC6008204</span></span></span></span></span></span></span><span
class=MsoHyperlink><span style='font-size:14.0pt;border:none'><br>
<br>
</span></span></p>

<h3 style='margin:0in;margin-bottom:.0001pt;text-indent:0in'><span
style='font-size:14.0pt;text-decoration:none'>4.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><span style='font-size:14.0pt'>Expanding the traditional view of
the hippocampal representation of space.</span></h3>

<p class=MsoNormal style='margin-left:.5in'><span style='font-size:14.0pt'>The
discovery of the hippocampal place cell (O’Keefe and Dostrovsky, 1971) provided
convincing physiological evidence that the hippocampus creates a cognitive map
of the environment. Since their original discovery, it has been determined that
“place cells” respond to many other behaviorally relevant features such as
goals, contexts, trajectories, and the passage of time. My research helped challenge
the traditional view of that hippocampal principal cells solely conveyed
spatial information. Together with Drew Maurer and Bruce McNaughton, we
determined that inhibitory also interneurons convey precise information about
space if one considers the phase of the theta rhythm at which interneurons fires<sup>3</sup>.
We used this phase-based definition of the place field to improve existing
measures of place-field features<sup>2</sup>. </span></p>

<p class=MsoNormal style='margin-left:.5in;line-height:50%'><span
style='font-size:14.0pt;line-height:50%'>&nbsp;</span></p>

<p class=MsoNormal style='margin-left:.5in'><span style='font-size:14.0pt'>The
second way my research extended the traditional understanding of hippocampal
function was through Dr. Douglas Nitz and my investigation of “repeating place
fields” - a recently discovered phenomenon whereby multiple place fields appear
when animals visit locations with similar behavioral or visual features. I
observed that these repeating fields shift forward in space as animals run on
spiral-shaped tracks. Further experiments revealed that this shift was most
likely due to a buildup of inertial navigation error, suggesting that animals
were using an inertial/vestibular strategy as opposed to a visual cue-based
navigation strategy – even in brightly-lit rooms. This is an interesting contribution
as one assumption in the field was that inertial navigational strategies are
only employed when visual cues are unavailable, and our results suggests that
the locations of goals can determine which navigation strategy is employed in
the hippocampus.</span></p>

<p class=MsoListParagraphCxSpFirst style='margin-left:1.0in;text-indent:-.25in'><span
style='font-size:14.0pt;border:none'>a.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><b><span style='font-size:14.0pt;border:none'><span
style='border:none'>Cowen SL</span></span></b><span style='font-size:14.0pt;
border:none'><span style='border:none'>, Nitz DA (2014) Repeating Firing Fields
of CA1 Neurons Shift Forward in Response to Increasing Angular Velocity. J
Neurosci 34:232–241.<span style='border:none'> <span style='border:none'>PMCID:
PMC6608168</span></span></span></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.0in;text-indent:-.25in'><span
style='font-size:14.0pt;border:none'>b.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><span style='font-size:14.0pt;border:none'><span
style='border:none'>Maurer AP, </span></span><b><span style='font-size:14.0pt;
border:none'><span style='border:none'>Cowen SL</span></span></b><span
style='font-size:14.0pt;border:none'><span style='border:none'>, Burke SN,
Barnes CA<span style='border:none'>, McNaughton BL (2006<span style='border:
none'>a<span style='border:none'>) Organization of hippocampal cell assemblies
based on theta phase precession. <span style='border:none'>Hippocampus.
2006;16(9):785-94.<span style='border:none'> <span style='border:none'>PMID:
16921501</span></span></span></span></span></span></span></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.0in;text-indent:-.25in'><span
style='font-size:14.0pt;border:none'>c.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><span style='font-size:14.0pt;border:none'><span
style='border:none'>Maurer AP, </span></span><b><span style='font-size:14.0pt;
border:none'><span style='border:none'>Cowen SL</span></span></b><span
style='font-size:14.0pt;border:none'><span style='border:none'>, Burke SN,
Barnes CA, McNaughton BL (2006b) Phase precession in hippocampal interneurons<span
style='border:none'> showing strong functional coupling to individual pyramidal
cells. J Neurosci 26:13485–13492.<span style='border:none'> <span
style='border:none'>PMCID: PMC6674718</span></span></span></span></span></p>

<p class=MsoListParagraphCxSpLast style='margin-left:1.0in'><span
style='font-size:14.0pt;border:none'>&nbsp;</span></p>

<h3 style='margin:0in;margin-bottom:.0001pt;text-indent:0in'><span
style='font-size:14.0pt;text-decoration:none'>5.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><span style='font-size:14.0pt'>Advancing measurement technologies
for the neuroscience community.</span></h3>

<p class=MsoNormal style='margin-left:.5in'><span style='font-size:14.0pt'>From
the onset of my scientific career, I have worked to develop hardware and
software to assist the neuroscience community. Below is a list of some of these
contributions and ongoing projects:</span></p>

<p class=MsoListParagraph style='margin-left:1.0in;text-indent:-.25in'>a.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </span><b><span
style='font-size:14.0pt;border:none'><span style='border:none'>Simultaneous
dopamine and single-unit/local-field measurement</span></span></b><span
style='font-size:14.0pt;border:none'><span style='border:none'>. Awarded a 2014
NSF BRAIN EAGER grant to develop technologies for the simultaneous recording of
the activities of ensembles of neurons and real-time measurement of dopamine
release. Since receiving support, we have <span style='border:none'>produced<span
style='border:none'> working versions of this device<span style='border:none'>
and successfully tested the device in anesthetized and awake and behaving rats
(Parent et al., 2017). The next stage of development will be to improve the
hardware and software to improve robustness and ease of use. <br>
<span style='border:none'>Contribution: Experiment design, softw<span
style='border:none'>are development, data analysis and discussion, wrote
manuscript.</span></span></span></span></span></span></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.0in;text-indent:-.25in'>b.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </span><b><span
style='font-size:14.0pt;border:none'><span style='border:none'>Improving
voltammetric measurement of dopamine concentration</span></span></b><span
style='font-size:14.0pt;border:none'><span style='border:none'> by reducing the
effects of biofou<span style='border:none'>ling (Seaton et al., 2020) and
improving safety and FDA compliance (Siegenthaler et al., 2020). C<span
style='border:none'>ontribution: Experimental and facilities support, review of
manuscript.</span></span></span></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.25in;text-indent:-.25in'><span
style='font-size:14.0pt;border:none'>a.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><span style='font-size:14.0pt;border:none'><span
style='border:none'>Seaton BT, Hill DF, </span></span><b><span
style='font-size:14.0pt;border:none'><span style='border:none'>Cowen SL</span></span></b><span
style='font-size:14.0pt;border:none'><span style='border:none'>, Heien ML C.
2020. Mitigating the Effects of Electrode Biofouling-Induced Impedance for
Improved Long-Term Electrochemical Measurements In Vivo. Anal Chem <span
style='border:none'>92:6334–6340.<span style='border:none'> PMCID: PMC8281608</span></span></span></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:1.25in;text-indent:-.25in'><span
style='font-size:14.0pt;border:none'>b.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;
</span></span><span style='font-size:14.0pt;border:none'><span
style='border:none'>Siegenthaler JR, Gushiken BC, Hill DF, </span></span><b><span
style='font-size:14.0pt;border:none'><span style='border:none'>Cowen SL</span></span></b><span
style='font-size:14.0pt;border:none'><span style='border:none'>, Heien ML C.
2020. Moving Fast-Scan Cyclic Voltammetry toward FDA Compliance with Capacitive
Decoupling Patient Protection. ACS sensors 5:1890–1899.<span style='border:
none'> </span></span></span></p>

<p class=MsoListParagraph style='margin-left:1.0in;text-indent:-.25in'>c.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span
style='font-size:14.0pt;border:none'><span style='border:none'>Ultrasound
measurement of <span style='border:none'>electrical brain activity. I am a
collaborator on Brain Initiative R24 (Lead PI: Russel Witte, U of A) to develop
a non-invasive ultrasound system for the measurement of electrical activity in
the brain. The system capitalizes on the acoustoelectric effect<span
style='border:none'>, and my role is to validate the system’s effectiveness by
comparing </span></span></span></span><i><span style='font-size:14.0pt;
border:none'><span style='border:none'>in vivo </span></span></i><span
style='font-size:14.0pt;border:none'><span style='border:none'>measurements
obtained from the ultrasound system with measurements obtained from traditional
electrophysiology. <br>
<span style='border:none'>Contribution: Experiment design, software
development, data analys<span style='border:none'>is and discussion</span></span></span></span></p>

<p class=MsoListParagraph style='margin-left:1.0in'><span style='font-size:
14.0pt;border:none'>&nbsp;</span></p>

<p class=MsoNormal><b><span style='font-size:14.0pt'>Complete List of Published
Work in MyBibliography:</span></b></p>

<p class=MsoNormal><span style='font-size:14.0pt'><a
href="https://www.ncbi.nlm.nih.gov/myncbi/stephen.cowen.1/bibliography/public/"><span
style='background:white'>https://www.ncbi.nlm.nih.gov/myncbi/stephen.cowen.1/bibliography/public/</span></a></span><span
style='font-size:14.0pt;color:black;background:white'> </span></p>

<p class=MsoNormal><b><span style='font-size:14.0pt'>&nbsp;</span></b></p>

</div>

</body>

</html>
